ENSG
The Ensign Group, Inc.
NASDAQ · USHealthcareMedical - Care Facilities
$172.04+0.44%
Price as of Jul 20, 2026
ENSG financials
The Ensign Group, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $5.1B | $4.3B | $3.7B | $3.0B |
| Cost of revenue | $4.3B | $3.6B | $3.1B | $2.5B |
| Gross profit | $799.5M | $667.6M | $590.8M | $518.0M |
| Operating expenses | $374.1M | $309.3M | $335.4M | $221.2M |
| Operating income | $425.3M | $358.3M | $255.4M | $296.8M |
| Net income | $344.0M | $298.0M | $209.4M | $224.7M |
| EBITDA | $567.9M | $478.5M | $353.2M | $360.4M |
| Basic EPS | $6.00 | $5.26 | $3.76 | $4.09 |
| Diluted EPS | $5.84 | $5.12 | $3.65 | $3.95 |
| Balance sheet | ||||
| Cash & equivalents | $503.9M | $464.6M | $509.6M | $316.3M |
| Total assets | $5.5B | $4.7B | $4.2B | $3.5B |
| Total liabilities | $3.2B | $2.8B | $2.7B | $2.2B |
| Stockholders’ equity | $2.2B | $1.8B | $1.5B | $1.2B |
| Total debt | $4.2B | $2.0B | $1.9B | $1.6B |
| Net debt | $3.7B | $1.5B | $1.4B | $1.3B |
| Cash flow | ||||
| Operating cash flow | $564.3M | $347.2M | $376.7M | $272.5M |
| Capital expenditure | -$193.6M | -$158.2M | -$106.2M | -$87.5M |
| Free cash flow | $370.7M | $188.9M | $270.5M | $185.0M |
| Dividends paid | -$14.4M | -$13.7M | -$12.9M | -$12.2M |
| Share repurchases | -$21.4M | -$1.2M | -$1.9M | -$31.6M |